Therapeutic B-cell depletion reverses progression of Alzheimer’s disease
Alzheimer’s disease is characterized by progressive dementia and amyloid beta plaque deposition. Here the authors show in three relevant transgenic animal models that accumulation of activated B cells is central to AD pathology and depletion of B cells interferes with both histological and behaviour...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-22479-4 |
id |
doaj-44ad602eff5f455e94eb988bbdc2dcdc |
---|---|
record_format |
Article |
spelling |
doaj-44ad602eff5f455e94eb988bbdc2dcdc2021-04-18T11:12:54ZengNature Publishing GroupNature Communications2041-17232021-04-0112111110.1038/s41467-021-22479-4Therapeutic B-cell depletion reverses progression of Alzheimer’s diseaseKi Kim0Xin Wang1Emeline Ragonnaud2Monica Bodogai3Tomer Illouz4Marisa DeLuca5Ross A. McDevitt6Fedor Gusev7Eitan Okun8Evgeny Rogaev9Arya Biragyn10Immunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingImmunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingImmunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingImmunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingThe Mina and Everard Goodman faculty of Life SciencesImmunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingMouse Phenotyping Unit, Comparative Medicine Section, National Institute on AgingDepartment of Genomics and Human Genetics, Institute of General Genetics, Russian Academy of SciencesThe Mina and Everard Goodman faculty of Life SciencesDepartment of Genomics and Human Genetics, Institute of General Genetics, Russian Academy of SciencesImmunoregulation Section, Laboratory of Immunology and Molecular Biology, National Institute on AgingAlzheimer’s disease is characterized by progressive dementia and amyloid beta plaque deposition. Here the authors show in three relevant transgenic animal models that accumulation of activated B cells is central to AD pathology and depletion of B cells interferes with both histological and behavioural manifestations of the disease.https://doi.org/10.1038/s41467-021-22479-4 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ki Kim Xin Wang Emeline Ragonnaud Monica Bodogai Tomer Illouz Marisa DeLuca Ross A. McDevitt Fedor Gusev Eitan Okun Evgeny Rogaev Arya Biragyn |
spellingShingle |
Ki Kim Xin Wang Emeline Ragonnaud Monica Bodogai Tomer Illouz Marisa DeLuca Ross A. McDevitt Fedor Gusev Eitan Okun Evgeny Rogaev Arya Biragyn Therapeutic B-cell depletion reverses progression of Alzheimer’s disease Nature Communications |
author_facet |
Ki Kim Xin Wang Emeline Ragonnaud Monica Bodogai Tomer Illouz Marisa DeLuca Ross A. McDevitt Fedor Gusev Eitan Okun Evgeny Rogaev Arya Biragyn |
author_sort |
Ki Kim |
title |
Therapeutic B-cell depletion reverses progression of Alzheimer’s disease |
title_short |
Therapeutic B-cell depletion reverses progression of Alzheimer’s disease |
title_full |
Therapeutic B-cell depletion reverses progression of Alzheimer’s disease |
title_fullStr |
Therapeutic B-cell depletion reverses progression of Alzheimer’s disease |
title_full_unstemmed |
Therapeutic B-cell depletion reverses progression of Alzheimer’s disease |
title_sort |
therapeutic b-cell depletion reverses progression of alzheimer’s disease |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2021-04-01 |
description |
Alzheimer’s disease is characterized by progressive dementia and amyloid beta plaque deposition. Here the authors show in three relevant transgenic animal models that accumulation of activated B cells is central to AD pathology and depletion of B cells interferes with both histological and behavioural manifestations of the disease. |
url |
https://doi.org/10.1038/s41467-021-22479-4 |
work_keys_str_mv |
AT kikim therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT xinwang therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT emelineragonnaud therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT monicabodogai therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT tomerillouz therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT marisadeluca therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT rossamcdevitt therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT fedorgusev therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT eitanokun therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT evgenyrogaev therapeuticbcelldepletionreversesprogressionofalzheimersdisease AT aryabiragyn therapeuticbcelldepletionreversesprogressionofalzheimersdisease |
_version_ |
1721522603416354816 |